Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kasen Shi

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
The Prostate|December 10, 2025
Prostate Cancer Cells With the AR-Low and EMT-High Phenotype Are Vulnerable to NAD+ Synthesis InhibitorsHyun-Kyung Ko, Rebecca L Foertsch, Kasen Shi, et al.
The Prostate|April 11, 2025
Understanding Enzalutamide-Resistance Based on a Functional Single-Cell ApproachChanghui Xue, Hyun-Kyung Ko, Kasen Shi, et al.
Biorxiv : the Preprint Server for Biology|November 1, 2024
Understanding the development of enzalutamide resistance based on a functional single-cell approachChanghui Xue, Hyun-Kyung Ko, Kasen Shi, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
The Prostate|December 10, 2025
Prostate Cancer Cells With the AR-Low and EMT-High Phenotype Are Vulnerable to NAD+ Synthesis InhibitorsHyun-Kyung Ko, Rebecca L Foertsch, Kasen Shi, et al.
The Prostate|April 11, 2025
Understanding Enzalutamide-Resistance Based on a Functional Single-Cell ApproachChanghui Xue, Hyun-Kyung Ko, Kasen Shi, et al.
Biorxiv : the Preprint Server for Biology|November 1, 2024
Understanding the development of enzalutamide resistance based on a functional single-cell approachChanghui Xue, Hyun-Kyung Ko, Kasen Shi, et al.
Pageof 1